Belll Palsy 3
Belll Palsy 3
Belll Palsy 3
Received 08/11/2022 1. Department of Otorhinolaryngology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences,
Review began 09/23/2022 Wardha, IND
Review ended 10/05/2022
Published 10/11/2022
Corresponding author: Awantika Singh, [email protected]
© Copyright 2022
Singh et al. This is an open access article
distributed under the terms of the Creative
Commons Attribution License CC-BY 4.0.,
which permits unrestricted use, distribution, Abstract
and reproduction in any medium, provided
Bell's palsy, also known as “acute facial palsy of unknown cause”, is a common cranial neuropathy leading to
the original author and source are credited.
facial muscle paresis or complete paralysis characteristically on one side, occurring suddenly and may
progress over 48 hours. It results from facial nerve dysfunction due to trauma or inflammation of the 7th
cranial nerve or facial nerve or its branches along its course, primarily in the bony canal. Both sexes are
equally affected, and though no age is immune, its incidence rises with increasing age. The risk is high in
diabetics, hypertensives, women who are pregnant, obese, and people with upper respiratory tract
infections. It is considered chiefly idiopathic and is diagnosed by the exclusion of other causes. Bell's palsy
can cause physical and psychological complications and negatively impact patients and their relatives.
Thus, early diagnosis and quick cause determination are prime roles in proper treatment. However, the exact
etiology of Bell's palsy is unknown, affecting its treatment. Still, determining probable causative and risk
factors is critical for employing a targeted treatment approach and requires a comprehensive examination
and a complete history. Although the majority of patients recover spontaneously in less than three weeks
even if they are not treated. But there is always a risk of residual paresis after treatment or recovery, which
may require medical help. This review aims to furnish the most thorough understanding of Bell's palsy,
focusing on anatomy, etiology, clinical features, diagnosis, clinical consequences, and preferred therapy
approaches.
An introductory study of the neuroanatomy of the nerve can help discern the difference between a central
and a peripheral lesion. Because the management differs with different etiology, this distinction is critical.
With the doubtful utility of antivirals, these are primarily recommended in combination with
corticosteroids. Patients showing signs of improvement within the first three weeks of the development of
symptoms have a higher chance of complete recovery; therefore, the sooner the healing begins, the lesser
the chance of developing complications and residual paraesthesias. Four to 14 percent of patients may
experience recurrence, with 36 percent suffering from palsy on the same side [6].
Background
Bell's palsy is named after Sir Charles Bell (1774-1842). Although he was the first to present the anatomical
basis of Bell's palsy, recent research has revealed that other European practitioners contributed earlier
clinical descriptions and accounts of the seventh peripheral cranial nerve palsy [7]. The first case report of
idiopathic facial paralysis is believed to have been published by an 18th-century medicine
professor, Nicolaus Friedrich, in Wurzburg. The case report described three middle-aged men with similar
episodes of unilateral facial paralysis, which was subacute or acute in origin and gradually bettered in a few
weeks to months. Later, Charles Bell studied facial nerve function in animals. He encountered several
unilateral facial nerve paralysis cases during his surgical practice in London. His most well-known and
widely cited case of facial palsy was posted in 1828, in which he presented a matter of a man hit by a bull
and the resulting injury caused perpetual facial nerve paralysis [8].
Review
Anatomical perspective
For a better comprehension of the etiopathogenesis of Bell's palsy, basic knowledge about the course and
innervations of the facial nerve is required. The facial nerve has three nuclei: motor, sensory and
parasympathetic nuclei. The course of the facial nerve can be divided into six segments. The first segment is
the intracranial segment which comprises of facial nerve's motor nucleus located in the pons from where the
motor fibers originate, hook around the abducens nerve nucleus, and are joined by the intermediate nerve
which carries sensory and parasympathetic components. Further, this mixed nerve passes through the
posterior cranial fossa and enters the bony facial canal (fallopian canal) through the anterior superior
quadrant of the internal acoustic meatus. This is known as the meatal or canalicular segment. Inside the
inner ear, the facial nerve passes in the fallopian canal in between the cochlea and vestibule and then bends
posteriorly at the geniculate ganglion (first genu). This segment is the shortest and narrowest and is most
prone to inflammation and ischemia. It is known as the labyrinthine segment. The labyrinthine segment
extends and forms the tympanic segment in the middle ear, takes another turn just distal to the pyramidal
eminence (second genu), and passes vertically downwards as the mastoid segment. The bony fallopian canal
in many cases can be dehiscent in some areas and thus more susceptible to damage. The mastoid segment
starts from the second genu, gives off its branches, and ends at the stylomastoid foramen forming the
extratemporal segment. It further passes in between the superficial and deep lobes of the parotid gland and
finally terminates into five branches at the anterior border of the gland [8,9].
The facial nerve gives efferent motor supply to all the muscles of facial expression, the stapedius, the
posterior belly of the digastric muscles, and parasympathetic and sensory fibers [10]. These parasympathetic
fibers supply the submandibular and the lacrimal glands via the chorda tympani and the greater superficial
petrosal nerve, respectively [8]. Therefore all these fibers and structures are susceptible to paralysis in case
of any damage to the facial nerve. Extended and convoluted pathways and presence in a narrow bony canal
make the 7th cranial nerve more prone to paralysis than all other nerves in the body [11].
Etiopathogenesis
Although the precise pathogenesis of Bell’s palsy is not known and considered idiopathic, specific immune,
ischemic and hereditary factors strongly correlate with its etiology. Based on recent reports, the reactivation
of dormant herpes virus in the geniculate ganglion and its migration to the facial nerve has been considered
to be vital in causation [8,12]. Herpes zoster virus (HZV) and herpes simplex virus (HSV) are human
neurotropic alpha herpes viruses and are most commonly involved [13]. These may remain latent life-long in
the ganglia [14]. HZV virus is considered more aggressive as it spreads across the nerve via satellite cells.
Usually, herpes simplex is involved in causing cold sores and genital herpes, whereas herpes zoster is
causative of chickenpox and shingles. The infection is said to be latent when there is no active viral
replication, but in the presence of antibodies or immunodeficient states, nerve damage and inflammation of
the facial nerve may occur, resulting in its further compression due to its fact in a narrow bony canal. Other
viruses known to be involved in the causation of Bell's palsy are Epstein Barr virus causing infectious
mononucleosis, cytomegalovirus, adenovirus, mumps virus, influenza B, etc. [15].
Vascular ischemia may be primary, secondary, or tertiary. Primary ischemic neuropathy, which causes
inflammation of the afflicted nerve, is more prone to take place in specific clinical circumstances, such as
diabetes mellitus [10]. It is usually induced by cold or emotional stress. Even though the facial nerve has
good vascularity and a tough epineurium, vasospasms can cause a reduction in blood flow and acute
inflammation, resulting in primary ischemic neuritis, which is uncommon [16]. It may be followed by
secondary ischemia, which further aggravates nerve damage by causing increased capillary permeability
leading to fluid accumulation, edema, and thus nerve compression [17]. In about 4-14% of individuals,
hereditary predisposition narrows the fallopian canal. This genetic component is mostly autosomal
dominant and put the nerve at additional risk of early compression with even the slightest edema [18].
Other symptoms include hyperacusis caused by nerve fiber breakdown in the stapedius muscle, alterations
in taste, and dry eyes caused by parasympathetic affliction. Some patients report facial paresthesia, which is
usually motor symptoms misinterpreted as sensory alteration and present with sensory or hearing loss [20].
2 Mild dysfunction Slight weakness noticeable on close inspection; may have very slight synkinesis
Moderate Obvious, but not disfiguring, difference between two sides; noticeable, but not severe, synkinesis,
3
dysfunction contracture, or hemifacial spasm; complete eye closure with effort
Moderately severe
4 Obvious weakness or disfiguring asymmetry; normal symmetry and tone at rest; incomplete eye closure
dysfunction
Wrinkling on the forehead on the ipsilateral side is absent or appears asymmetric while raising the eyebrows.
The ipsilateral eye shows partial closure and may remain slightly open when the patient attempts to close
his eyes, and the involved eyelid may slightly lag when the patient blinks. The examiner can demonstrate
Bell's phenomenon by attempting to open the eyelids of the patient while he is asked to shut the lids tightly.
The eyes, in such a case, deviate upwards and laterally. This procedure can also assess the strength of the
orbicularis oculi muscle. Careful ear examination for cholesteatoma, acute suppurative otitis media, chronic
suppurative otitis media, malignant otitis media, and any other signs of middle ear disease is required. Red
chorda tympani (vascular flaring of the tympanometry area) is seen in Bell's palsy. Various audiometric tests
like pure tone audiometry, speech audiometry, brainstem evoked response audiometry, and special tests can
be performed to rule out cochlear and retrocochlear lesions.
To know which segment of the facial nerve is involved, physicians should perform prognostic tests like
tearing, salivation, taste, and stapedial reflex, while electrodiagnostic tests will reveal the depth of damage.
The diagnosis of Bell's palsy is mainly clinical, and it is made by ruling out alternative causes of unilateral
facial paralysis [23]. Electrodiagnostic tests performed within 14 days of commencement may provide
prognostic information. The majority of cases of facial paralysis are caused by some other ailment that
mimics Bell's palsy, such as a central lesion like stroke or demyelinating disease, cholesteatoma, parotid
gland tumor, middle ear infections, Lyme disease, diabetes, granulomatous disease, Ramsay-Hunt
syndrome, trauma, and Guillain-Barré syndrome [20,24,25].
A careful history, complete head and neck, and otological examination are paramount, along with radiologic
studies, blood tests such as peripheral smear, total count, blood sugar, sedimentation rate, and serology.
Whether or not the forehead muscle is involved in paralysis can help in clinically determining whether the
palsy of the facial nerve is due to central causes like stroke or is peripheral. The upper part of the facial
nerve nucleus, which supplies the frontalis muscle, receives fibers from both the cerebral hemispheres. In
contrast, the lower part of the nucleus supplying the lower and middle face gets only crossed fibers from one
hemisphere, so if the lower and central portion of the face is paralyzed, but the function of the frontalis is
preserved, the lesion must be supranuclear. The absence of forehead wrinkles, incomplete closure of eyelids,
sagging of eyebrows, flattened nasolabial folds, and stooping of the corner of the mouth are all common
symptoms of peripheral facial nerve palsy.
Nerve excitability tests are done regularly to monitor nerve degeneration. They record the least value of
electrical stimulus, which can produce a visible muscle contraction, thus helping determine the excitation
threshold. The excitation threshold of the involved side is then compared with that of the uninvolved side,
and if the difference is more than 3.5 mA, the prognosis is poor. Imaging and laboratory tests are more
reliable in patients showing no betterment in symptoms even after three weeks of therapy or those with
recurrence [8]. Intensification of nerve in MRI when correlated with history and examination is diagnostic of
Bell’s palsy. Intensification of tympanic and vertical segments may occur in a normal person, but
specifically, labyrinthine segment intensification is seen in Bell's palsy [26].
Motor nerve conduction studies and electromyography of the facial nerve can aid in the patient's
Treatment
Most patients usually have a good prognosis. According to The Copenhagen Facial Nerve Study, the majority
of patients recover completely, around 13 percent suffer slight paresis and 4 to 5 percent are left with
significant facial dysfunction [27]. As spontaneous recovery is usual, the treatment is still controversial, but
medical treatment and therapies help relieve symptoms and hasten recovery.
Prednisone and other oral corticosteroids reduce nerve swelling and may speed up the recovery of facial
actions and expressions. These medications are most efficacious when started within 48 hours of the onset
of symptoms [12]. When taken with corticosteroids, antiviral drugs such as acyclovir for herpes are known to
hasten the healing. This combination has a short treatment period and is cost-effective thus is very often
recommended unless contraindicated [28]. Ear pain can be relieved with the use of analgesics.
Oral corticosteroids, such as prednisone, reduce nerve swelling and might improve facial motions and
expressions faster [29]. This treatment is most efficacious when it is started within 48 hours of noticing
symptoms [30]. The suggested dose of prednisone is 60 mg orally once a day for five days which is then
tapered to 10 mg per day [31]. Antivirals like acyclovir (Zovirax®) can be initiated at a dose of 400 mg orally
five times a day and continued for 10 days in case of associated herpes infection. Figure 2 describes the
complete management of a patient with Bell's palsy according to the course of the disease.
If paralysis does not improve in six-eight weeks, facial nerve decompression can be tried by an opening
sheath or eggshell bone removal. In severe cases, for those who don't recover, functional facial plastic
surgery procedures can be an option to correct facial asymmetry and help with eyelid closure. Laser
acupuncture is also tried in parts of Asia for patients with acute bell's palsy, though its role in chronic Bell's
palsy is still questionable [34]. It is a painless, non-invasive mode of treatment used in various inflammatory
painful conditions and can be an effective modality in patients with inadequate recovery from Bell's
palsy [35].
Conclusions
Bell's palsy is an ipsilateral, idiopathic, and acute lower motor neuron paralysis of the seventh cranial nerve
that causes weakening of the platysma and facial muscles and significantly impacts the patient's appearance
and the standard of living and psychosocial well-being. Symptoms begin with mild weakness in facial
muscles without any neurologic abnormalities and peak in the first week and then steadily diminish over
three weeks to three months even without any medical treatment but may result in various complications
Diagnosis is one of exclusion and requires a vigilant history and thorough clinical examination. If stipulated
by medical history or risk factors, testing for Lyme disease and diabetes can be suggested. Incomplete closure
of lids with resultant dry eye, dysphagia, and slurred speech are common short-term complications. An
uncommon long-term complication is contractures and the permanent weakening of facial muscles.
Although most patients undergo spontaneous recovery, treatment with a short course of valacyclovir or
acyclovir and a tapering dose of prednisone, started within three days of the
appearance of symptoms, is considered to shorten the time and chance of complete recovery.
Additional Information
Disclosures
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the
following: Payment/services info: All authors have declared that no financial support was received from
any organization for the submitted work. Financial relationships: All authors have declared that they have
no financial relationships at present or within the previous three years with any organizations that might
have an interest in the submitted work. Other relationships: All authors have declared that there are no
other relationships or activities that could appear to have influenced the submitted work.
References
1. Ton G, Lee LW, Ng HP, et al.: Efficacy of laser acupuncture for patients with chronic Bell's palsy: a study
protocol for a randomized, double-blind, sham-controlled pilot trial. Medicine (Baltimore). 2019, 98:e15120.
10.1097/MD.0000000000015120
2. Bosco D, Plastino M, Bosco F, et al.: Bell's palsy: a manifestation of prediabetes? . Acta Neurol Scand. 2011,
123:68-72. 10.1111/j.1600-0404.2010.01365.x
3. Aditya V: LMN facial palsy in pregnancy: an opportunity to predict preeclampsia-report and review . Case
Rep Obstet Gynecol. 2014, 2014:626871. 10.1155/2014/626871
4. Peng KP, Chen YT, Fuh JL, Tang CH, Wang SJ: Increased risk of Bell palsy in patients with migraine: a
nationwide cohort study. Neurology. 2015, 84:116-24. 10.1212/WNL.0000000000001124
5. Khateri M, Cheraghi S, Ghadimi A, Abdollahi H: Radiation exposure and Bell’s palsy: a hypothetical
association. J Biomed Phys Eng. 2018, 8:337-40.
6. Bell’s Palsy Recovery . (2009). Accessed: August 31, 2021: https://www.news-medical.net/health/Bells-Palsy-
Recovery.aspx.
7. Sajadi MM, Sajadi MR, Tabatabaie SM: The history of facial palsy and spasm: Hippocrates to Razi .
Neurology. 2011, 77:174-8. 10.1212/WNL.0b013e3182242d23
8. Zandian A, Osiro S, Hudson R, Ali IM, Matusz P, Tubbs SR, Loukas M: The neurologist's dilemma: a
comprehensive clinical review of Bell's palsy, with emphasis on current management trends. Med Sci Monit.
2014, 20:83-90. 10.12659/MSM.889876
9. Facial nerve. (2022). Accessed: July 25, 2022: https://radiopaedia.org/articles/facial-nerve.
10. Zhang W, Xu L, Luo T, Wu F, Zhao B, Li X: The etiology of Bell's palsy: a review . J Neurol. 2020, 267:1896-
905. 10.1007/s00415-019-09282-4
11. Michaels L: Histopathological changes in the temporal bone in Bell's palsy . Acta Otolaryngol Suppl. 1990,
470:114-7; discussion 118. 10.3109/00016488909138364
12. Eviston TJ, Croxson GR, Kennedy PG, Hadlock T, Krishnan AV: Bell's palsy: aetiology, clinical features and
multidisciplinary care. J Neurol Neurosurg Psychiatry. 2015, 86:1356-61. 10.1136/jnnp-2014-309563
13. Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman LM: Global and regional
estimates of prevalent and incident herpes simplex virus Type 1 infections in 2012. PLoS One. 2015,
10:e0140765. 10.1371/journal.pone.0140765
14. Bell’s palsy - Symptoms and causes . Accessed: July 13, 2022: https://www.mayoclinic.org/diseases-
conditions/bells-palsy/symptoms-causes/syc-20370028..
15. Kennedy PG, Rovnak J, Badani H, Cohrs RJ: A comparison of herpes simplex virus type 1 and varicella-zoster
virus latency and reactivation. J Gen Virol. 2015, 96:1581-602. 10.1099/vir.0.000128
16. Newadkar UR, Chaudhari L, Khalekar YK: Facial palsy, a disorder belonging to influential neurological
dynasty: review of literature. N Am J Med Sci. 2016, 8:263-7. 10.4103/1947-2714.187130
17. Grewal DS: Bell's palsy-tertiary ischemia: an etiological factor in residual facial palsy . Indian J Otolaryngol
Head Neck Surg. 2018, 70:374-9. 10.1007/s12070-018-1381-9
18. Skuladottir AT, Bjornsdottir G, Thorleifsson G, et al.: A meta-analysis uncovers the first sequence variant
conferring risk of Bell's palsy. Sci Rep. 2021, 11:4188. 10.1038/s41598-021-82736-w
19. Everything about Bell’s Palsy . (2018). Accessed: July 25, 2022: https://dentagama.com/news/bells-palsy-
unilateral-facial-paralysis.
20. Patel DK, Levin KH: Bell palsy: Clinical examination and management . Cleve Clin J Med. 2015, 82:419-26.
10.3949/ccjm.82a.14101
21. Portelinha J, Passarinho MP, Costa JM: Neuro-ophthalmological approach to facial nerve palsy. Saudi J
Ophthalmol. 2015, 29:39-47. 10.1016/j.sjopt.2014.09.009
22. House Brackmann. Accessed: July 26, 2022: https://sorensenclinic.com/microsurgery/house-brackmann/.
23. McAllister K, Walker D, Donnan PT, Swan I: Surgical interventions for the early management of Bell's palsy .
Cochrane Database Syst Rev. 2013, CD007468. 10.1002/14651858.CD007468.pub3
24. Hohman MH, Hadlock TA: Etiology, diagnosis, and management of facial palsy: 2000 patients at a facial